BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33463549)

  • 1. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.
    Sharma R; Reinstadler B; Engelstad K; Skinner OS; Stackowitz E; Haller RG; Clish CB; Pierce K; Walker MA; Fryer R; Oglesbee D; Mao X; Shungu DC; Khatri A; Hirano M; De Vivo DC; Mootha VK
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report.
    Fukuda M; Nagao Y
    J Med Case Rep; 2019 Oct; 13(1):313. PubMed ID: 31630688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An mtDNA mutation, 14453G-->A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome.
    Ravn K; Wibrand F; Hansen FJ; Horn N; Rosenberg T; Schwartz M
    Eur J Hum Genet; 2001 Oct; 9(10):805-9. PubMed ID: 11781695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
    Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D
    Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS).
    Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Suomalainen A; Hakonen AH; Carroll CJ; Rodenburg RJ; de Laat PB; Janssen MCH; Smeitink JAM; Louw R
    Mitochondrion; 2019 Mar; 45():38-45. PubMed ID: 29471047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitochondrial genome analysis in the probands of six Chinese families with MELAS].
    Liu L; Yuquan S; Baorong Z; Pingping J; Ailian D; Minxin G
    Yi Chuan; 2014 Nov; 36(11):1159-67. PubMed ID: 25567874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and metabolomic advances uncover biomarkers of mitochondrial disease pathophysiology and severity.
    Gucek M; Sack MN
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the
    Endres D; Süß P; Maier SJ; Friedel E; Nickel K; Ziegler C; Fiebich BL; Glocker FX; Stock F; Egger K; Lange T; Dacko M; Venhoff N; Erny D; Doostkam S; Komlosi K; Domschke K; Tebartz van Elst L
    Front Immunol; 2019; 10():412. PubMed ID: 30949164
    [No Abstract]   [Full Text] [Related]  

  • 11. The mitochondrial DNA 10197 G > A mutation causes MELAS/Leigh overlap syndrome presenting with acute auditory agnosia.
    Leng Y; Liu Y; Fang X; Li Y; Yu L; Yuan Y; Wang Z
    Mitochondrial DNA; 2015 Apr; 26(2):208-12. PubMed ID: 24708134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic uniqueness in an individual with MELAS.
    Vanniarajan A; Nayak D; Reddy AG; Singh L; Thangaraj K
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):440-4. PubMed ID: 16741938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.
    Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotype heterogeneity associated with mitochondrial DNA A3243G mutation].
    Zhang Y; Wang ZX; Niu SL; Xu YF; Pei P; Yuan Y; Yang YL; Qi Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):77-80. PubMed ID: 15782498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Variation in m.3243A > G Mutation Produce Discrete Changes in Energy Metabolism.
    McMillan RP; Stewart S; Budnick JA; Caswell CC; Hulver MW; Mukherjee K; Srivastava S
    Sci Rep; 2019 Apr; 9(1):5752. PubMed ID: 30962477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood genome-wide expression profiling and network analysis suggest MELAS master regulators.
    Mende S; Royer L; Herr A; Schmiedel J; Deschauer M; Klopstock T; Kostic VS; Schroeder M; Reichmann H; Storch A
    Neurol Res; 2011 Jul; 33(6):638-55. PubMed ID: 21708074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, pathological and molecular biological characteristics of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episode in children].
    Liu XL; Bao XH; Ma YN; Chang XZ; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):130-5. PubMed ID: 23527980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral lactic acidosis correlates with neurological impairment in MELAS.
    Kaufmann P; Shungu DC; Sano MC; Jhung S; Engelstad K; Mitsis E; Mao X; Shanske S; Hirano M; DiMauro S; De Vivo DC
    Neurology; 2004 Apr; 62(8):1297-302. PubMed ID: 15111665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy Characteristics and Clinical Outcome in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS).
    Lee HN; Eom S; Kim SH; Kang HC; Lee JS; Kim HD; Lee YM
    Pediatr Neurol; 2016 Nov; 64():59-65. PubMed ID: 27671241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.